Rasilez HCT® (aliskiren and hydrochlorothiazide) received a positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) recommending marketing authorization as a new treatment for high blood pressure. Rasilez HCT is a single-pill combination of two high blood pressure medicines Read the rest of this entry »
Archive for November, 2008
Use Of Low-Cost Diuretics To Treat High Blood Pressure Did Not Increase After Study Showing Effectiveness
25 Nov 2008
The use of low-cost, generic diuretics to treat high blood pressure did not increase significantly following a 2002 study that found the drugs were more effective at treating hypertension than newer drugs that were up to 20 times more expensive, the New York Times reports. The National Heart, Lung and Blood Institute in 1994 began enrolling high blood Read the rest of this entry »
If you think your ragweed allergies are getting worse, you may be right. And global warming may be the culprit, according to the American Academy of Allergy, Asthma & Immunology.
That’s not good news for the estimated 36 million Americans who suffer from ragweed allergy, the primary cause of fall allergy Read the rest of this entry »
While doctors are urged to start with a diuretic-based strategy to control patients’ high blood pressure, an international blood pressure study shows a different single-pill drug combination is more effective at preventing heart-related events such as heart attacks and strokes. The findings challenge the way blood pressure is usually treated worldwide.
The randomized study led by a University Read the rest of this entry »
New clinical data presented show first-in-class direct renin inhibitor Rasilez® (aliskiren), known as Tekturna® in the US, provides significantly greater blood pressure reductions in patients with high blood pressure aged 65 and over, compared to the angiotensin-converting enzyme (ACE) inhibitor ramipril[1].
Results from the Read the rest of this entry »